GLP is the quality system used to collect safety data on a product being developed for non-clinical health and environmental safety studies.

Prepare for the Biotechnology EOPA Exam with our comprehensive study materials. Use flashcards and multiple-choice questions, each with hints and explanations. Ensure your success with thorough exam preparation!

Multiple Choice

GLP is the quality system used to collect safety data on a product being developed for non-clinical health and environmental safety studies.

Explanation:
GLP establishes a quality framework for how non-clinical safety studies are planned, conducted, monitored, recorded, reported, and archived. It ensures that safety data generated on a product before human testing are reliable and traceable, which is essential for regulatory decisions. In practice, GLP covers written study plans and protocols, proper data collection and handling of raw data, calibrated and validated equipment, trained personnel, and an independent quality assurance unit that audits compliance. This system is specifically aimed at non-clinical health and environmental safety studies, such as toxicology and environmental fate assessments, to build confidence in the data that will support safety evaluations. It is not about clinical trial reporting (that’s GCP), nor a labeling standard for reagents, nor a containment level for pathogens, which is why this option best describes GLP.

GLP establishes a quality framework for how non-clinical safety studies are planned, conducted, monitored, recorded, reported, and archived. It ensures that safety data generated on a product before human testing are reliable and traceable, which is essential for regulatory decisions. In practice, GLP covers written study plans and protocols, proper data collection and handling of raw data, calibrated and validated equipment, trained personnel, and an independent quality assurance unit that audits compliance. This system is specifically aimed at non-clinical health and environmental safety studies, such as toxicology and environmental fate assessments, to build confidence in the data that will support safety evaluations. It is not about clinical trial reporting (that’s GCP), nor a labeling standard for reagents, nor a containment level for pathogens, which is why this option best describes GLP.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy